Recombinant
RabMAb

Anti-PIAS1 antibody [EPR2580(2)] (ab109388)

Publishing research using ab109388? Please let us know so that we can cite the reference in this datasheet.

ab109388 has been referenced in 7 publications.

  • Chanda A  et al. Identification of the SUMO E3 ligase PIAS1 as a potential survival biomarker in breast cancer. PLoS One 12:e0177639 (2017). WB, IF ; Human . PubMed: 28493978
  • Bogachek MV  et al. Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal Carcinomas. Stem Cell Reports 7:1140-1151 (2016). PubMed: 27916539
  • Du L  et al. Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal. Nat Commun 7:12326 (2016). IHC-P ; Human . PubMed: 27465491
  • Campia I  et al. An Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer Cells. PLoS One 10:e0126159 (2015). WB . PubMed: 25955018
  • Toropainen S  et al. SUMO ligase PIAS1 functions as a target gene selective androgen receptor coregulator on prostate cancer cell chromatin. Nucleic Acids Res 43:848-61 (2015). PubMed: 25552417
  • Chiou HY  et al. Hes-1 SUMOylation by protein inhibitor of activated STAT1 enhances the suppressing effect of Hes-1 on GADD45a expression to increase cell survival. J Biomed Sci 21:53 (2014). WB . PubMed: 24894488
  • Li R  et al. Akt SUMOylation regulates cell proliferation and tumorigenesis. Cancer Res 73:5742-53 (2013). WB ; Human . PubMed: 23884910

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up